Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer
3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]
Lumakras Plus Vectibix improves PFS in colorectal cancer
Patients with colorectal cancer had improved progression-free survival with the combination of Lumaclas and Vectibix. Treatment with Lumaclas (sotorasib) in combination with Vectibix (panitumumab) at multiple dose levels significantly increases patient progression-free survival (PFS) and disease progression from random assignment in clinical trials compared to standard of care (SOC). (time to progression or death).Have chemotherapy-resistant […]